When Canada legalized recreational cannabis in 2018, there were still many unknown implications for health care, industry and the country at large. So the government made a promise: after three years, it would review the law to ensure its policies worked.
Members of Smitherman’s council were among the 500 people from 200 organizations, who spoke to the five Cannabis Act review panelists about the law’s successes and failures. Beena Goldenberg, the chief executive of Moncton-based licensed producer Organigram Holdings Inc., wants federal and provincial governments to rethink the excise taxes charged to pot producers.
Other retailers told the government panel they want to be able to label products that come from a family-run company, are made with organic ingredients or are sun-grown. Some say they should to be able to promote pot as freely as tobacco or alcohol companies market their products.
And the medical community is insistent changes shouldn’t come at a cost to public health. Many remain supportive of the cautionary approach to cannabis the country took. Some want even stricter limits on who can possess, distribute and buy pot, the government’s report said.They’re being cautious in part because the Canadian Institute for Health Information has said cannabis-related emergency department visits and hospitalizations both increased 14 per cent between 2019 and 2021.
“Last year, our government announced the launch of the legislative review of the Cannabis Act,” Christopher Aoun said in an email.Goldenberg suspects convincing the government to make changes won’t be a speedy process and she worries some companies won’t survive the wait because many are already on the brink of bankruptcy.
ایران آخرین اخبار, ایران سرفصلها
Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.
منبع: YahooFinanceCA - 🏆 47. / 63 ادامه مطلب »
منبع: SooToday - 🏆 8. / 85 ادامه مطلب »
منبع: globeandmail - 🏆 5. / 92 ادامه مطلب »
منبع: globeandmail - 🏆 5. / 92 ادامه مطلب »